Novozymes A/S is a Danish biotechnology company that develops, produces and markets industrial enzymes and microorganisms. Headquartered in Bagsværd, Denmark, the company focuses on using biological solutions to improve industrial processes across a range of end markets. Its offerings are designed to increase product performance or process efficiency while reducing energy, water and chemical consumption for customers.
The company’s product portfolio includes enzymes and microbial solutions for household care (detergents and cleaning products), food and beverages (baking, brewing and dairy applications), bioenergy (enzymes for biofuel production), agriculture (microbial crop inputs and biocontrols) and industrial processing (textiles, pulp and paper, and wastewater treatment). Novozymes combines enzyme formulation, strain development and fermentation manufacturing capabilities to supply tailored solutions and technical support to manufacturer customers.
Novozymes serves a global customer base through direct sales and partnerships, supplying producers and brand owners in major markets worldwide. The firm emphasizes research and development, continually investing in discovery, protein engineering and process development to improve enzyme performance and broaden application areas. Sustainability is a central theme in its value proposition, as many of its products enable customers to lower environmental footprints and meet regulatory or consumer-driven sustainability targets.
Historically, Novozymes traces its roots to the industrial enzyme activities that were part of the Novo group and later became an independent, publicly traded company; it is also available to investors via an OTC listing under the symbol NVZMY. The company’s strategy centers on innovation, commercial partnerships and scaling biomanufacturing to address both established markets and emerging opportunities for biological solutions.
AI Generated. May Contain Errors.
Free NVZMY Stock Alerts